Franklin Resources, Inc. 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 11:43 am Sale | 2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX | FRANKLIN RESOURCES INC BEN | 6,404,795 4.300% | -5,462,985 (-46.03%) | Filing |
| 2023-01-31 1:12 pm Sale | 2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX | FRANKLIN RESOURCES INC BEN | 11,867,780 10.000% | -99,685 (-0.83%) | Filing |
| 2022-02-03 3:01 pm Sale | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | FRANKLIN RESOURCES INC BEN | 11,967,465 11.700% | -721,237 (-5.68%) | Filing |
| 2021-02-01 2:39 pm Purchase | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | FRANKLIN RESOURCES INC BEN | 12,688,702 14.000% | 327,291 (+2.65%) | Filing |
| 2020-02-04 4:37 pm Purchase | 2019-12-31 | 13G | Heron Therapeutics, Inc. HRTX | FRANKLIN RESOURCES INC BEN | 12,361,411 13.700% | 3,940,120 (+46.79%) | Filing |